home > news > detailed info

Mobile-Optimised Continuous Monitoring System from Vaisala Enhances Product Safety

Vaisala Ltd

Vaisala has launched viewLinc 4.0, a new version of its monitoring, alarming and reporting software, which is the heart of the Vaisala Continuous Monitoring System. Aimed at highly demanding controlled and regulated environments in the pharmaceutical and biotechnology industries, the new version offers an optimized mobile interface for remote monitoring and alarm management. This, along with the location-based reporting and data logging capability, allows users to act on alarms immediately, anywhere and anytime on their smart phones, to improve product safety and ensure compliance with GMP and other regulations.

Other key features include a greatly enhanced user interface that is easier to navigate and more customization capabilities in historical reports and live multiple-channel trend display for enhanced reporting. Users can now create reports more quickly in preparation for and during field quality audits.

"We are ecstatic with the Vaisala viewLinc Monitoring System! It not only helps us meet FDA regulatory and accreditation requirements, but we can now monitor multiple sites from any location," states Brad Bayette, Tissue Services Manager at US-based tissue bank.

The improved user interface facilitates easy access to product data in a more familiar Windows-type navigation. In addition, it shows data by location, which allows users to easily find their loggers, swap out devices, and report data by location. With the mobile interface, users can acknowledge and pause alarms, view live trends on any monitored location under their control, and view trend data in real-time.

"Like its predecessors, Vaisala viewLinc 4.0 is easily deployed for monitoring temperature, relative humidity, CO2, differential pressure, level, door switches, and more. But, we built this version of viewLinc based on working closely with viewLinc users. Every new feature and interface capability came from feedback and suggestions we got. viewLinc 4.0 addresses the changing needs of our customers and integrates new technologies and user expectations, such as drag and drop and mobile usage," says Jon Aldous, Product Manager for Vaisala's Life Science business.

Vaisala will offer its customers warranty, software upgrades, technical support and user training services. Language localized versions will be available in May 2012 in French, Chinese, German and Japanese.
phone +44 (0) 121 683 5620
email Bury St Edmunds Office, Unit 2b Hillside Business Park, Kempson Way, Bury St Edmunds, Suffolk, IP32 7EA
Print this page
Send to a friend
News and Press Releases

CPhI Worldwide experts predict CDMO mega-mergers and Chinese patented products imminent

HPAPI growth driven by virtual and mid-sized pharma, with biosimilars expanding rapidly in Europe
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

RDD Asia 2016

8-11 November 2016, Grand Hyatt Hotel, Goa, India

RDD Asia 2016, jointly organized by RDD Online and Aptar Pharma, represents the extension of US and European RDD meetings into one of the world's prominent emerging markets and a hotbed of inhaler development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement